Clinical Trials on 抗生素毒性 in China
总计88个结果
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...未知
-
Cancer Institute and Hospital, Chinese Academy...招聘中化疗毒性 | 放射治疗;并发症 | PARP抑制剂 | 免疫检查点抑制剂 | 曲妥珠单抗 | 乳腺癌,家族性男性 | CDK4/6 抑制剂 | 帕妥珠单抗中国
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Peking University People's HospitalPeking University; Northwestern University未知对 Famitinib 和 Camrelizumab 的耐药性 | 疗效和毒性的生物标志物中国
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Peking University People's HospitalChinese Sarcoma Study Group招聘中
-
Peking University People's HospitalPeking University Shougang Hospital暂停
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中
-
Peking University People's HospitalPeking University Shougang Hospital完全的
-
Women's Hospital School Of Medicine Zhejiang UniversityQilu Hospital of Shandong University; Huazhong University of Science and Technology; West China...招聘中
-
The First Affiliated Hospital of Hunan University...主动,不招人
-
Haiyan LiPeking University; Food and Drug Administration (FDA); Spaulding Clinical Research LLC; BioClinica...未知
-
Affiliated Hospital of Qinghai University尚未招聘
-
G1 Therapeutics, Inc.终止结直肠癌转移 | 化疗毒性 | 骨髓抑制-成人中国, 西班牙, 美国, 匈牙利, 英国, 波兰, 乌克兰, 意大利